These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 19774499)
21. Pleiomorphism plurihormonal Pit-1-positive macroadenoma with central hyperthyroidism: a rare case report and literature review. Peng G; Guo C; Lv Y; Li D; Zhou L; Shen R; Chen Y; Zheng X; Sun Z; Zheng H; Long M BMC Endocr Disord; 2022 Dec; 22(1):325. PubMed ID: 36539773 [TBL] [Abstract][Full Text] [Related]
22. Diagnosis and treatment of pituitary adenomas. Chanson P; Salenave S Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032 [TBL] [Abstract][Full Text] [Related]
27. A thyrotropin-secreting macroadenoma with positive growth hormone and prolactin immunostaining: A case report and literature review. Kuzu F; Bayraktaroğlu T; Zor F; G N BD; Salihoğlu YS; Kalaycı M Niger J Clin Pract; 2015; 18(5):693-7. PubMed ID: 26096253 [TBL] [Abstract][Full Text] [Related]
28. GH-, PRL-, POMC-, beta-TSH-, beta-LH-, beta-FSH-mRNA in gonadotroph adenomas of the pituitary by in situ hybridization in comparison with immunostaining and clinical data. Münscher A; Schmid M; Saeger W; Schreiber S; Lüdecke DK Endocr Pathol; 2001; 12(2):171-80. PubMed ID: 11579683 [TBL] [Abstract][Full Text] [Related]
29. [Non-functioning pituitary adenomas: clinical features and immunohistochemistry]. Ferreira JE; de Mello PA; de Magalhães AV; Botelho CH; Naves LA; Nosé V; Schmitt F Arq Neuropsiquiatr; 2005 Dec; 63(4):1070-8. PubMed ID: 16400431 [TBL] [Abstract][Full Text] [Related]
30. Clinical and immunohistochemical studies on TSH-secreting pituitary adenoma: its multihormonality and expression of Pit-1. Sanno N; Teramoto A; Matsuno A; Inada K; Itoh J; Osamura RY Mod Pathol; 1994 Dec; 7(9):893-9. PubMed ID: 7892156 [TBL] [Abstract][Full Text] [Related]
35. Clinical Importance of Somatostatin Receptor 2 (SSTR2) and Somatostatin Receptor 5 (SSTR5) Expression in Thyrotropin-Producing Pituitary Adenoma (TSHoma). Yu B; Zhang Z; Song H; Chi Y; Shi C; Xu M Med Sci Monit; 2017 Apr; 23():1947-1955. PubMed ID: 28434012 [TBL] [Abstract][Full Text] [Related]
36. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients. Trouillas J; Labat-Moleur F; Sturm N; Kujas M; Heymann MF; Figarella-Branger D; Patey M; Mazucca M; Decullier E; Vergès B; Chabre O; Calender A; Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794 [TBL] [Abstract][Full Text] [Related]
37. Does the response of GH-secreting pituitary adenomas to octreotide depend on the cellular localization of the somatostatin receptor subtypes SSTR2 and SSTR5? Pisarek H; Pawlikowski M; Kunert-Radek J; Winczyk K Endokrynol Pol; 2010; 61(2):178-81. PubMed ID: 20464704 [TBL] [Abstract][Full Text] [Related]
38. Induction of GH, PRL, and TSH beta mRNA by transfection of Pit-1 in a human pituitary adenoma-derived cell line. Miyai S; Yoshimura S; Iwasaki Y; Takekoshi S; Lloyd RV; Osamura RY Cell Tissue Res; 2005 Nov; 322(2):269-77. PubMed ID: 16133148 [TBL] [Abstract][Full Text] [Related]
39. Ultrastructural characteristics of TSH-producing adenomas with special reference to its close similarity to BFA-treated pituitary adenoma cells. Ikeda H; Ogawa Y; Yoshimoto T Pituitary; 1999 May; 1(3-4):221-6. PubMed ID: 11081201 [TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical detection of human natural killer cell like immunoreactivity in human pituitary adenomas, using monoclonal antibody NK-1. Sanno N; Itoh J; Teramoto A; Itoh Y; Hori S; Osamura RY J Neurooncol; 1997 Oct; 35(1):29-38. PubMed ID: 9266438 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]